Cargando…
Regulatory Networks of LncRNA MALAT-1 in Cancer
Long noncoding (lnc)RNAs are a group of RNAs with a length greater than 200 nt that do not encode a protein but play an essential role in regulating the expression of target genes in normal biological contexts as well as pathologic processes including tumorigenesis. The lncRNA metastasis-associated...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575067/ https://www.ncbi.nlm.nih.gov/pubmed/33116873 http://dx.doi.org/10.2147/CMAR.S276022 |
_version_ | 1783597742256291840 |
---|---|
author | Fu, Shijian Wang, Yanhong Li, Hang Chen, Leilei Liu, Quanzhong |
author_facet | Fu, Shijian Wang, Yanhong Li, Hang Chen, Leilei Liu, Quanzhong |
author_sort | Fu, Shijian |
collection | PubMed |
description | Long noncoding (lnc)RNAs are a group of RNAs with a length greater than 200 nt that do not encode a protein but play an essential role in regulating the expression of target genes in normal biological contexts as well as pathologic processes including tumorigenesis. The lncRNA metastasis-associated lung adenocarcinoma transcript (MALAT)-1 has been widely studied in cancer. In this review, we describe the known functions of MALAT-1; its mechanisms of action; and associated signaling pathways and their clinical significance in different cancers. In most malignancies, including lung, colorectal, thyroid, and other cancers, MALAT-1 functions as an oncogene and is upregulated in tumors and tumor cell lines. MALAT-1 has a distinct mechanism of action in each cancer type and is thus at the center of large gene regulatory networks. Dysregulation of MALAT-1 affects cellular processes such as alternative splicing, epithelial–mesenchymal transition, apoptosis, and autophagy, which ultimately results in the abnormal cell proliferation, invasion, and migration that characterize cancers. In other malignancies, such as glioma and endometrial carcinoma, MALAT-1 functions as a tumor suppressor and thus forms additional regulatory networks. The current evidence indicates that MALAT-1 and its associated signaling pathways can serve as diagnostic or prognostic biomarker or therapeutic target in the treatment of many cancers. |
format | Online Article Text |
id | pubmed-7575067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75750672020-10-27 Regulatory Networks of LncRNA MALAT-1 in Cancer Fu, Shijian Wang, Yanhong Li, Hang Chen, Leilei Liu, Quanzhong Cancer Manag Res Review Long noncoding (lnc)RNAs are a group of RNAs with a length greater than 200 nt that do not encode a protein but play an essential role in regulating the expression of target genes in normal biological contexts as well as pathologic processes including tumorigenesis. The lncRNA metastasis-associated lung adenocarcinoma transcript (MALAT)-1 has been widely studied in cancer. In this review, we describe the known functions of MALAT-1; its mechanisms of action; and associated signaling pathways and their clinical significance in different cancers. In most malignancies, including lung, colorectal, thyroid, and other cancers, MALAT-1 functions as an oncogene and is upregulated in tumors and tumor cell lines. MALAT-1 has a distinct mechanism of action in each cancer type and is thus at the center of large gene regulatory networks. Dysregulation of MALAT-1 affects cellular processes such as alternative splicing, epithelial–mesenchymal transition, apoptosis, and autophagy, which ultimately results in the abnormal cell proliferation, invasion, and migration that characterize cancers. In other malignancies, such as glioma and endometrial carcinoma, MALAT-1 functions as a tumor suppressor and thus forms additional regulatory networks. The current evidence indicates that MALAT-1 and its associated signaling pathways can serve as diagnostic or prognostic biomarker or therapeutic target in the treatment of many cancers. Dove 2020-10-15 /pmc/articles/PMC7575067/ /pubmed/33116873 http://dx.doi.org/10.2147/CMAR.S276022 Text en © 2020 Fu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Fu, Shijian Wang, Yanhong Li, Hang Chen, Leilei Liu, Quanzhong Regulatory Networks of LncRNA MALAT-1 in Cancer |
title | Regulatory Networks of LncRNA MALAT-1 in Cancer |
title_full | Regulatory Networks of LncRNA MALAT-1 in Cancer |
title_fullStr | Regulatory Networks of LncRNA MALAT-1 in Cancer |
title_full_unstemmed | Regulatory Networks of LncRNA MALAT-1 in Cancer |
title_short | Regulatory Networks of LncRNA MALAT-1 in Cancer |
title_sort | regulatory networks of lncrna malat-1 in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575067/ https://www.ncbi.nlm.nih.gov/pubmed/33116873 http://dx.doi.org/10.2147/CMAR.S276022 |
work_keys_str_mv | AT fushijian regulatorynetworksoflncrnamalat1incancer AT wangyanhong regulatorynetworksoflncrnamalat1incancer AT lihang regulatorynetworksoflncrnamalat1incancer AT chenleilei regulatorynetworksoflncrnamalat1incancer AT liuquanzhong regulatorynetworksoflncrnamalat1incancer |